Extract
We thank E.H. Walters and co-workers for their interest in our recently published research letter “Stability of eosinophilic inflammation in COPD bronchial biopsies” [1]. We would like to provide clarity on several points raised.
Abstract
Correspondence: stability of eosinophilic inflammation in COPD bronchial biopsies https://bit.ly/35IrOlu
Footnotes
Conflict of interest: A. Higham reports personal fees from Chiesi, outside the submitted work.
Conflict of interest: D. Singh reports personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, GlaxoSmithKline, Glenmark, Gossamerbio, Menarini, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Theravance and Verona, outside the submitted work.
- Received November 12, 2020.
- Accepted November 13, 2020.
- Copyright ©ERS 2020
LIBRARY USERS
Log in through your institution
If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.